• SENSEX
    NIFTY 50
Business

10 things you need to know before the opening bell on May 6

Updated : May 06, 2021 08:22 AM IST

The Indian market is likely to open higher on Thursday following gains in global markets. The trend on SGX Nifty also indicates a positive start for the broader index in India. The Nifty futures were trading 44.0 points or 0.30 percent higher at the 14737.0 level on the Singaporean Exchange at 8:10 am.

 1. Wall Street  | The Dow Jones Industrial Average ended at a record high on Wednesday, driven higher by energy and other economically sensitive sectors, while the Nasdaq closed in red as megacap growth stocks slipped. The Dow closed at 34,230.34, up by 0.29 percent, while the S&P 500 gained 2.93 points, or 0.07 percent, to 4,167.59. The Nasdaq Composite gave up its earlier gains and ended 51.08 points, or 0.37 percent, lower at 13,582.43.
1. Wall Street | The Dow Jones Industrial Average ended at a record high on Wednesday, driven higher by energy and other economically sensitive sectors, while the Nasdaq closed in red as megacap growth stocks slipped. The Dow closed at 34,230.34, up by 0.29 percent, while the S&P 500 gained 2.93 points, or 0.07 percent, to 4,167.59. The Nasdaq Composite gave up its earlier gains and ended 51.08 points, or 0.37 percent, lower at 13,582.43.
 2. Asian stocks  | Asian markets were mostly higher as investors look ahead to the US jobs report due later this week for clues about how long the Fed will stay on hold. Nikkei 225 jumped 1.98 percent while the Topix index was up 1.97 percent. South Korea’s Kospi rose 0.7 percent. In Hong Kong, the Hang Seng index was up 1.15 percent.
2. Asian stocks | Asian markets were mostly higher as investors look ahead to the US jobs report due later this week for clues about how long the Fed will stay on hold. Nikkei 225 jumped 1.98 percent while the Topix index was up 1.97 percent. South Korea’s Kospi rose 0.7 percent. In Hong Kong, the Hang Seng index was up 1.15 percent.
 3. Indian market on Wednesday  | The Indian equity indices ended higher Wednesday led by strong gains across the board after the Reserve Bank of India (RBI) Governor Shaktikanta Das announced a slew of measures to support small businesses amid the second wave of pandemic. The Sensex surged 424.04 points, or 0.88 percent to close at 48,677.55, while the Nifty ended 121.35 points, or 0.84 percent higher, at 14,617.85. Barring Nifty Realty, all other sectoral indices closed in the green with Nifty Pharma jumping over 4 percent followed by Nifty PSU Bank, Nifty IT and Nifty Metal.
3. Indian market on Wednesday | The Indian equity indices ended higher Wednesday led by strong gains across the board after the Reserve Bank of India (RBI) Governor Shaktikanta Das announced a slew of measures to support small businesses amid the second wave of pandemic. The Sensex surged 424.04 points, or 0.88 percent to close at 48,677.55, while the Nifty ended 121.35 points, or 0.84 percent higher, at 14,617.85. Barring Nifty Realty, all other sectoral indices closed in the green with Nifty Pharma jumping over 4 percent followed by Nifty PSU Bank, Nifty IT and Nifty Metal.
 4. Crude Oil  | Oil prices fell on Thursday as gasoline inventories in the United States, the world's largest oil consumer, rose for a fifth consecutive week although a draw in crude stockpiles helped to underpin prices. Brent crude oil futures fell by 16 cents, or 0.2 percent, to $68.80 barrel, and US West Texas Intermediate (WTI) crude futures dropped by 20 cents, or 0.3 percent, to $65.43 a barrel.
4. Crude Oil | Oil prices fell on Thursday as gasoline inventories in the United States, the world's largest oil consumer, rose for a fifth consecutive week although a draw in crude stockpiles helped to underpin prices. Brent crude oil futures fell by 16 cents, or 0.2 percent, to $68.80 barrel, and US West Texas Intermediate (WTI) crude futures dropped by 20 cents, or 0.3 percent, to $65.43 a barrel.
 5. Rupee  | The rupee snapped its two-day winning streak and closed 6 paise lower at 73.91 against the US currency on Wednesday due to forex outflows and a stronger dollar in overseas markets. Gains in Indian equities and the COVID relief steps announced by the RBI on Wednesday restricted the rupee’s fall. At the interbank foreign exchange market, the domestic unit opened higher at 73.80, but failed to maintain the gains and fell to 74.04 before ending at 73.91, a loss of 6 paise over its previous close.
5. Rupee | The rupee snapped its two-day winning streak and closed 6 paise lower at 73.91 against the US currency on Wednesday due to forex outflows and a stronger dollar in overseas markets. Gains in Indian equities and the COVID relief steps announced by the RBI on Wednesday restricted the rupee’s fall. At the interbank foreign exchange market, the domestic unit opened higher at 73.80, but failed to maintain the gains and fell to 74.04 before ending at 73.91, a loss of 6 paise over its previous close.
 6. Gold subdued on firmer dollar  | Gold prices inched lower on Thursday due to a stronger dollar, while investors awaited the release of US non-farm payrolls data for April due later this week. Spot gold was down 0.1 percent at $1,785.05 per ounce. US gold futures was steady at $1,785.10 per ounce. The dollar index hovered close to a two-week high, making gold more expensive for other currency holders.
6. Gold subdued on firmer dollar | Gold prices inched lower on Thursday due to a stronger dollar, while investors awaited the release of US non-farm payrolls data for April due later this week. Spot gold was down 0.1 percent at $1,785.05 per ounce. US gold futures was steady at $1,785.10 per ounce. The dollar index hovered close to a two-week high, making gold more expensive for other currency holders.
 7. Roche gets emergency use authorisation for Casirivimab, Imdevimab in India for COVID-19 treatment  | Roche India announced that the Central Drugs Standards Control Organisation (CDSCO) has provided an Emergency Use Authorisation (EUA) for its antibody cocktail Casirivimab and Imdevimab in India to treat COVID-19 patients. This approval was based on the data that have been filed for the EUA in the United States, and the scientific opinion of the Committee for Medicinal Products for Human Use (CHMP) in the European Union. This will enable Roche to import the globally manufactured product batches to India. Casirivimab and Imdevimab will be marketed and distributed in India through a strategic partnership with Cipla.
7. Roche gets emergency use authorisation for Casirivimab, Imdevimab in India for COVID-19 treatment | Roche India announced that the Central Drugs Standards Control Organisation (CDSCO) has provided an Emergency Use Authorisation (EUA) for its antibody cocktail Casirivimab and Imdevimab in India to treat COVID-19 patients. This approval was based on the data that have been filed for the EUA in the United States, and the scientific opinion of the Committee for Medicinal Products for Human Use (CHMP) in the European Union. This will enable Roche to import the globally manufactured product batches to India. Casirivimab and Imdevimab will be marketed and distributed in India through a strategic partnership with Cipla.
 8. US approves waiving intellectual property rules on vaccines  | The Biden administration is throwing its support behind efforts to waive intellectual property protections for COVID-19 vaccines in an effort to speed the end of the pandemic. United States Trade Representative Katherine Tai announced the government's position in a Wednesday statement, amid World Trade Organisation talks over easing global trade rules to enable more countries to produce more of the life-saving vaccines.
8. US approves waiving intellectual property rules on vaccines | The Biden administration is throwing its support behind efforts to waive intellectual property protections for COVID-19 vaccines in an effort to speed the end of the pandemic. United States Trade Representative Katherine Tai announced the government's position in a Wednesday statement, amid World Trade Organisation talks over easing global trade rules to enable more countries to produce more of the life-saving vaccines.
 9. Rs 8 lakh cr package needed to support lower income groups, says report  | The government will need to roll out a relief package worth Rs 8 lakh crore to contain hardships being faced by lower-income groups due to the economic impact of COVID-19, a report by Azim Premji University said on Wednesday. The report is based on inputs from Consumer Pyramids Household Survey, Azim Premji Foundation, and many other civil society organisations. As per the calculations based on CMIE-CPHS data, the report said, around 23 crore people are estimated to have fallen below the national minimum wage poverty line due to the impact of COVID-19 on the economy and around 1.5 crore workers remain jobless by the end of 2020, the report titled State of the Work 2021 said.
9. Rs 8 lakh cr package needed to support lower income groups, says report | The government will need to roll out a relief package worth Rs 8 lakh crore to contain hardships being faced by lower-income groups due to the economic impact of COVID-19, a report by Azim Premji University said on Wednesday. The report is based on inputs from Consumer Pyramids Household Survey, Azim Premji Foundation, and many other civil society organisations. As per the calculations based on CMIE-CPHS data, the report said, around 23 crore people are estimated to have fallen below the national minimum wage poverty line due to the impact of COVID-19 on the economy and around 1.5 crore workers remain jobless by the end of 2020, the report titled State of the Work 2021 said.
 10. Analysts say missing risk appetite may cap gains from RBI liquidity boost  | Analysts welcomed the additional liquidity measures announced by the RBI on Wednesday, but cautioned that the impact of these steps will largely depend on the risk appetite of lenders. Despite the massive liquidity boost last year, credit offtake had plunged to a 59-year-low of 5.6 per cent in FY21, they added. Domestic ratings agency Care Ratings said the additional RBI measures are likely to be beneficial to alleviate the constraints faced by a number of stakeholders in the economy. That the measured have been well-received is clear from the equity and bond markets where the bond yields declined.
10. Analysts say missing risk appetite may cap gains from RBI liquidity boost | Analysts welcomed the additional liquidity measures announced by the RBI on Wednesday, but cautioned that the impact of these steps will largely depend on the risk appetite of lenders. Despite the massive liquidity boost last year, credit offtake had plunged to a 59-year-low of 5.6 per cent in FY21, they added. Domestic ratings agency Care Ratings said the additional RBI measures are likely to be beneficial to alleviate the constraints faced by a number of stakeholders in the economy. That the measured have been well-received is clear from the equity and bond markets where the bond yields declined.
Published : May 06, 2021 08:22 AM IST
Live TV

recommended for you

Ask Our Experts CNBC TV18

Advertisement